The market for immunomodulating drugs is worth about R83 million, which is a decent size. Unfortunately, it's not growing, with zero year-on-year growth, so you'll need to compete for a share of the existing market. With 94 suppliers already in the mix, it's a fairly crowded space, and you'll need to stand out to get noticed by the two departments that buy these products. It's worth noting that black-owned businesses have a significant favour, with about 44% of the allocation, so if your business has a strong black ownership component, you may have an advantage. If I were you, I'd focus on building relationships with those two departments and highlighting your business's black ownership credentials to get a foot in the door.
ProTenders Intelligence, powered by National Treasury BAS data
R83M
94
2
R534K
B-BBEE Allocation
44.1%
R37M
6.1%
R5M
0.7%
R591K
0.3%
R250K
Spending Trend
By Province
Data from National Treasury BAS · Immunomodulating drugs · 94 suppliers across 2 departments · FY 2025/26